Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trazodone controlled-release - Angelini Group/Labopharm

Drug Profile

Trazodone controlled-release - Angelini Group/Labopharm

Alternative Names: AF-1161; DDS-04A; Oleptro; Trazodone Contramid OAD; Trazodone extended release; Trazodone HCl; Trazodone OAD; Triticum AC; Trittico

Latest Information Update: 12 Oct 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Angelini Group; Labopharm
  • Developer Altus Formulation Inc; Angelini Group; Lee's Pharmaceutical
  • Class Antidepressants; Erectile dysfunction therapies; Piperazines; Pyridines; Sleep disorder therapies; Small molecules; Triazoles
  • Mechanism of Action Serotonin 2A receptor antagonists; Serotonin 2C receptor antagonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Major depressive disorder
  • Phase II Diabetic neuropathies; Insomnia

Most Recent Events

  • 09 Aug 2018 Angelini Group completes a phase II trial in Diabetic neuropathies in Hungary, Poland, Czech Republic (PO) (NCT03202979)
  • 24 Jun 2018 Biomarkers information updated
  • 23 Feb 2017 Phase-II clinical trials in Diabetic neuropathies in Hungary (PO) (EudraCT2016-002772-27)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top